BlackRock, Inc. 13D and 13G filings for Checkpoint Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-05-07 5:09 pm Purchase | 2021-04-30 | 13G | Checkpoint Therapeutics, Inc. CKPT | BlackRock Inc. BLK | 348,761 4.800% | 24,702 (+7.62%) | Filing |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT | BlackRock Inc. BLK | 324,060 5.300% | 179,974 (+124.91%) | Filing |